CMTM5 acts as a tumor-suppressor gene, and it is downregulated in several cancers, such as myeloid leukemia, ovarian cancer, prostate cancer, cervical carcinoma, and pancreatic cancer [67]. Here, CMTM5 is linked to ovarian carcinoma.